SARS-CoV-2 Omicron Spike RBD and Antibody Set

Product Description

SARS-CoV-2 Omicron Spike RBD and Specific Antibody Set
Catalog number: B2010596
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 2 x 100 ug
Molecular Weight or Concentration: na
Supplied as: Solution
Applications: molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants
Storage: -20C
Keywords: SARS-CoV-2 Spike Antibody, Omicron Antibody, SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

Download SARS-CoV-2 Brochure

References:
1: Criscuolo E, Diotti RA, Ferrarese R, Alippi C, Viscardi G, Signorelli C,
Mancini N, Clementi M, Clementi N. Fast inactivation of SARS-CoV-2 by UV-C and
ozone exposure on different materials. Emerg Microbes Infect. 2021
Dec;10(1):206-210.

2: Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy
SN, Singh K. Infectivity of SARS-CoV-2: there Is Something More than D614G? J
Neuroimmune Pharmacol. 2020 Dec;15(4):574-577.

3: Zhou Y, Pei F, Ji M, Wang L, Zhao H, Li H, Yang W, Wang Q, Zhao Q, Wang Y.
Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection
kits and strategy to reduce false negative. PLoS One. 2020 Nov
18;15(11):e0241469.

4: Beck ET, Paar W, Fojut L, Serwe J, Jahnke RR. Comparison of the Quidel Sofia
SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of
COVID-19 in Symptomatic Outpatients. J Clin Microbiol. 2021 Jan
21;59(2):e02727-20.

5: Ginsburg I, Fibach E. Polycations and polyanions in SARS-CoV-2 infection. Med
Hypotheses. 2021 Jan;146:110470.

6: Luo Y, Yu F, Zhou M, Liu Y, Xia B, Zhang X, Liu J, Zhang J, Du Y, Li R, Wu L,
Zhang X, Pan T, Guo D, Peng T, Zhang H. Engineering a Reliable and Convenient
SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of
Antiviral Inhibitors. mBio. 2021 Jan 19;12(1):e02754-20.

7: Littler DR, MacLachlan BJ, Watson GM, Vivian JP, Gully BS. A pocket guide on
how to structure SARS-CoV-2 drugs and therapies. Biochem Soc Trans. 2020 Dec
18;48(6):2625-2641.

8: Antonelli G, Stefani S, Pistello M. SARS-CoV-2 diagnostics: Some reflections
on current assays. Diagn Microbiol Infect Dis. 2021 Feb;99(2):115237.

9: Wurtz N, Penant G, Jardot P, Duclos N, La Scola B. Culture of SARS-CoV-2 in a
panel of laboratory cell lines, permissivity, and differences in growth profile.
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):477-484.
10: Yano H, Nakano R, Suzuki Y, Nakano A, Kasahara K, Hosoi H. Inactivation of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone
treatment. J Hosp Infect. 2020 Dec;106(4):837-838.

Products Related to SARS-CoV-2 Omicron Spike RBD and Specific Antibody Set: Proteins